# Antoine Hollebecque

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/antoine-hollebecque/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,561 |
| Field | Fibroblast Growth Factor Research |
| h-index | 67 |
| i10-index | 242 |
| Last Known Institution | Institut Gustave Roussy |
| OpenAlex ID | https://openalex.org/A5086593040 |
| ORCID iD | https://orcid.org/0000-0003-2869-7551 |
| Works | 999 |

## Researcher papers

- [Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus](https://scholariq.org/papers/efficacy-and-safety-of-pembrolizumab-for-heavily-pretreated-patients-with/)
- [Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer](https://scholariq.org/papers/diverse-resistance-mechanisms-to-the-third-generation-alk-inhibitor-lorlatinib/)
- [The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer](https://scholariq.org/papers/the-clinical-landscape-of-cell-free-dna-alterations-in-1671-patients-with/)

## Researcher topics

- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Institut Gustave Roussy](https://scholariq.org/institutions/institut-gustave-roussy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.